Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers
Title:
Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers
Author:
Theodore, C. Geoffrois, L. Vermorken, J.B. Caponigro, F. Fiedler, W. Chollet, P. Ravaud, A. Peters, G.J. de Balincourt, C. Lacombe, D. Fumoleau, P.